MDLIVE
MDLIVE (now branded MD Live by Evernorth) is a telehealth platform offering virtual urgent care, primary care, dermatology, therapy, and psychiatry through licensed clinicians via video, phone, and mobile app. Owned by Evernorth, Cigna's health services division, it serves about 62 million members through health plan and employer benefits.
Score generated by AI agents based on publicly cited evidence and reviewed by the project maintainer. Not independently validated. Last assessed 2026-10-01. Score revised 2026-10-01: 52 → 41.
Score History
Timeline events are AI-curated from public reporting. Score trajectory is derived from documented events.
Randy Parker founded MDLIVE in South Florida in 2009 to offer 24/7 virtual visits with board-certified physicians at simple per-visit prices. It grew through insurer partnerships starting with Cigna in 2013, the 2014 Breakthrough Behavioral teletherapy acquisition and a Walgreens app partnership. The founder was replaced as CEO in 2016, and a 2017 class action over app screenshots sent to a testing vendor was voluntarily dismissed with no payment.
Cigna and Health Care Service Corporation led a $50 million round in August 2018, months before Cigna closed its $67 billion Express Scripts merger. Cigna opened MDLIVE behavioral health visits to its employer members from 2020, and COVID-19 nearly doubled visits in early 2020, with some patients reporting long waits. A September 2020 round valued MDLIVE at $1 billion ahead of a planned IPO, while access became increasingly tied to insurer benefits.
Evernorth completed its $2.0 billion acquisition of MDLIVE, ending its independence and IPO plans. Cigna's 2022 virtual-first plans steered employer members to MDLIVE primary care with $0 copays, and MDLIVE added remote patient monitoring and chronic condition management. The parent bought back $7.7 billion of stock in 2021 and targeted at least $7 billion in 2022, while the FTC opened its inquiry into Express Scripts and other PBMs in June 2022.
Evernorth bought Bright.md's technology, leading to MDLIVE's asynchronous E-Treatment in 2024, as Cigna began rolling layoffs, pivoted from Humana merger talks to a $10 billion buyback and bought back about $5 billion of stock in early 2024. Patient portal activity was allegedly shared with Google and Meta from May 2023 to August 2025, which MDLIVE settled for $3.5 million in 2026 without admitting wrongdoing. Complaint sites filled with billing grievances even as app ratings stayed high and MDLIVE won NCQA accreditation in March 2026. Express Scripts settled the FTC insulin case in February 2026 and Cigna cut about 2,000 jobs, then slowed buybacks sharply.
Alternatives
Transparent cash-pay telehealth with visits starting at $34, no insurance required and prices shown up front. Ideal for uninsured patients or anyone frustrated with MDLIVE's billing problems. Easy switch with no subscription needed.
A major telehealth platform offering urgent care, primary care and mental health services through health plans and employers. Easy switch for most one-off services, though ongoing psychiatric patients face re-establishment friction. Accepts many of the same insurance plans.
Dimensional Breakdown
Summaries below were written by AI agents based on the cited evidence. They are editorial interpretations, not independent research findings.
Dimension History
Timeline (51 events)
MDLIVE Founded as Independent Telehealth Startup
Randy Parker founded MDLIVE in 2009 in South Florida (headquartered in Sunrise), building a business offering 24/7 virtual access to board-certified physicians via video and phone. Parker came from outside medicine, having previously run a business selling movies to large retailers.
Cigna Healthcare Partners with MDLIVE for Member Access
Cigna Healthcare first engaged MDLIVE in 2013, giving Cigna members access to 24/7/365 virtual consultations for non-emergency medical issues. The vendor relationship became a strategic partnership after Cigna Ventures co-led a 2018 growth round, and culminated in acquisition eight years after the first engagement.
MDLIVE Acquires Breakthrough Behavioral for Teletherapy
MDLIVE acquired Silicon Valley-based Breakthrough Behavioral, a teletherapy provider available in ten states with five million members through customer contracts. MDLIVE said the deal made it the first single vendor providing both medical and behavioral health services for Commercial and Medicaid populations.
Walgreens Partners with MDLIVE for Mobile Telehealth
Walgreens and MDLIVE launched telehealth visits through the Walgreens mobile app (iOS and Android), initially available in California and Michigan with plans to roll out to more states. Users gained 24/7 access to U.S. board-certified physicians for a range of acute conditions, who could e-prescribe when appropriate.
Founder Randy Parker Replaced as CEO by Scott Decker
MDLIVE replaced founder Randy Parker with health IT veteran Scott Decker as CEO. Parker transitioned to chief business development officer and remained on the board. Decker brought 30 years of health IT experience from HealthSparq, signaling a shift from founder-driven innovation to professional management oriented toward scaling and enterprise partnerships.
Class Action Alleges MDLIVE App Sent Patient Screenshots to Testing Vendor
App user Joan Richards, represented by Edelson PC, filed a class action alleging the MDLIVE app took an average of 60 screenshots in its first 15 minutes of use, capturing sensitive health information, and sent them to Israeli quality-control firm Test Fairy without patients' knowledge. MDLIVE called the suit baseless and said the practice was consistent with its privacy policy. The plaintiff voluntarily dismissed all claims in June 2017, and MDLIVE said no settlement was paid.
Rich Berner Appointed MDLIVE CEO to Drive Growth
MDLIVE appointed Rich Berner as CEO effective January 1, 2018, replacing Scott Decker. Berner came from Allscripts, where he had led worldwide solution strategy for its health systems business. Under Berner's leadership, MDLIVE pursued growth partnerships with major insurers, ultimately positioning the company for acquisition by Cigna's Evernorth.
Cigna Announces $67 Billion Express Scripts Acquisition
Cigna announced a $67 billion deal to acquire Express Scripts, the nation's largest stand-alone pharmacy benefit manager, responsible for the prescription plans of more than 80 million Americans. The merger, which closed December 20, 2018, created a vertically integrated insurer-PBM entity, setting the stage for MDLIVE's eventual integration into a closed healthcare ecosystem where prescriptions would flow through Cigna-owned channels.
Cigna and HCSC Lead $50M Investment in MDLIVE
MDLIVE closed a $50 million growth investment round led by Cigna, Health Care Service Corporation, and Health Velocity Capital, with participation from Novo Holdings and Industry Ventures. The investment deepened Cigna's strategic stake in MDLIVE; CEO Richard Berner said it reflected payers' interest in integrating virtual care.
Cigna Rolls Out Express Scripts' AI Tool Health Connect 360
Cigna announced it would use Health Connect 360, an AI tool built by Express Scripts, to track patients' drug intake and adherence for chronic conditions such as diabetes and heart disease. The tool combines pharmacy claims, medical, lab and biometric data from connected devices; it was tested on 500,000 members and set for full availability in January 2020.
Cigna Expands MDLIVE Behavioral Health Access to 12.5M Members
Cigna announced that starting in January 2020 its 14 million customers in employer-sponsored plans could schedule video or phone appointments with behavioral health counselors, psychologists and psychiatrists through MDLIVE, covered at the same cost share as an in-office visit. MDLIVE's CEO said the expansion would add 12.5 million members, deepening integration between the two companies.
COVID-19 Drives MDLIVE Visit Surge
The COVID-19 pandemic drove a surge in MDLIVE usage. Following five consecutive years of more than 45% visit growth, MDLIVE's virtual visits rose more than 95% and total bookings more than 300% in the first half of 2020, and the company completed nearly 1 million patient visits through July 2020.
Ohio AG Sues Express Scripts for Millions in Prescription Overcharges
Ohio Attorney General Dave Yost filed suit against Express Scripts alleging the PBM 'egregiously' overcharged the Ohio Highway Patrol Retirement System by failing to meet pricing guarantees and repeatedly misclassifying generic drugs as brand-name medicines to inflate costs. The overcharges occurred across multiple years of the contract. The lawsuit foreshadowed the broader pattern of state enforcement actions against Express Scripts that would escalate after its integration with MDLIVE under Evernorth.
MDLIVE Reaches $1 Billion Valuation and Eyes IPO
MDLIVE closed a $50 million crossover equity investment led by Sixth Street Growth plus $25 million in debt, valuing the company at $1 billion. Chairman and CEO Charles Jones said MDLIVE aimed to go public in early 2021. The company reported serving 45 million members and completing nearly 1 million visits through July 2020, with behavioral health visits up more than 500% year over year.
Evernorth Announces MDLIVE Acquisition
Evernorth, Cigna's health services subsidiary, announced it would acquire MDLIVE, completing a transition from strategic investor to owner. Terms were not disclosed at announcement; Cigna's 2021 10-K later put the purchase price at $2.0 billion in cash. MDLIVE had been planning an IPO before the deal. The acquisition represented a key piece of Cigna's vertical integration strategy, bringing telehealth delivery in-house alongside Express Scripts' pharmacy and benefits services.
Evernorth Completes MDLIVE Acquisition
Evernorth completed its acquisition of MDLIVE, incorporating the telehealth platform into its portfolio of care delivery businesses. MDLIVE became part of the Evernorth ecosystem alongside Express Scripts, marking the end of MDLIVE's independence and the beginning of integration into Cigna's vertically integrated healthcare platform.
Cigna Launches Virtual-First Plans Built on MDLIVE Primary Care
Cigna announced virtual-first health plans for large, self-insured employers launching in 2022, with a $0 copay for MDLIVE primary care providers, chronic condition management and care navigation. Starting January 2022, Cigna members insured through their employer also gained access to MDLIVE's virtual primary care network. The structure channeled employer members toward MDLIVE and Evernorth's integrated care delivery.
MDLIVE Launches Remote Patient Monitoring with Biometric Data
MDLIVE launched its first patient health monitoring program, letting appropriate patients track and report biometrics such as blood pressure and glucose levels to their virtual primary care providers, with plans to add connected devices that transmit data automatically to the MDLIVE portal. The program extended MDLIVE's data collection from individual encounters to ongoing monitoring.
Cigna Reports $7.7 Billion in 2021 Share Buybacks
In its first full-year results after acquiring MDLIVE, Cigna reported repurchasing 35.2 million shares for $7.7 billion in 2021, raised its quarterly dividend 12% to $1.12 a share, and booked a charge for a plan to drive operational efficiency through organizational changes, automation and shared services.
FTC Launches Investigation into Six Largest PBMs
The FTC launched a sweeping investigation into the six largest pharmacy benefit managers including Express Scripts, CVS Caremark, and OptumRx, requiring them to turn over five years of records on business practices. The bipartisan 5-0 vote examined fees charged to unaffiliated pharmacies, methods to steer patients toward PBM-owned pharmacies, and the impact of manufacturer rebates on drug pricing.
Cigna Announces $3.5 Billion Accelerated Share Repurchase
Cigna said it would repurchase $3.5 billion of stock through accelerated repurchase agreements and remained on track to buy back at least $7 billion of shares in 2022. CEO David Cordani called it part of the company's 'ongoing commitment to return significant value to our shareholders.'
MDLIVE Adds Chronic Condition Management to Virtual Primary Care
MDLIVE announced it would add a structured chronic condition management program to its virtual primary care offering starting in 2023, initially for hypertension and expanding to other common chronic conditions. Nearly 17 million people had MDLIVE Virtual Primary Care as a covered benefit. Ongoing chronic care relationships deepen patients' ties to the platform, since switching means re-establishing longitudinal care elsewhere.
Cigna Return-to-Office Mandate Hits Long-Remote Workers
Cigna required employees who had been hired to work remotely, some long before COVID, to report to an office if they lived within 50 miles of one. A September 2023 Indeed review said the policy 'torpedoed morale' and people were leaving; reviewers said it appeared designed to push people to quit so Cigna could avoid severance.
Evernorth Acquires Bright.md for Asynchronous Care Integration
Evernorth acquired Bright.md's technology and clinical capabilities to add asynchronous care, triage and navigation to MDLIVE, launching in virtual urgent care in 2024. Patients complete a guided clinical interview that is converted into a chart note; a licensed clinician then reviews it and directs next steps. The model replaces real-time patient-clinician interaction for these visits.
MDLIVE Adds Welldoc-Powered Health Coaching for Chronic Conditions
Alongside the Bright.md deal, Evernorth added health coaching for chronic disease patients to MDLIVE's virtual primary care, powered by Welldoc. Coaches send personalized insights and reminders, patients record vitals through activity-tracking devices and manage medications, and MDLIVE physicians have access to this information.
Cigna Employees Report Staggered Layoff Waves
Cigna and Evernorth employees reported staggered layoffs beginning in fall 2023. An October 23, 2023 Indeed review said Cigna had just cut 2% of employees and was expected to lay off up to 10% over the next year; a November 2023 review described layoffs in waves of a couple hundred, and Glassdoor reviewers described monthly layoffs since October 2023 alongside offshore hiring to replace onshore technical staff.
Cigna Abandons Humana Merger, Announces $10B Buyback
Cigna abandoned acquisition talks with rival Humana after failing to agree on price, and announced $10 billion in additional share repurchases. The pivot from strategic acquisition to massive capital return signaled a prioritization of shareholder returns over business growth or service investment, with total buyback authorization reaching $11.3 billion.
MDLIVE Privacy Policy Reveals AI Processing of Visit Recordings
MDLIVE's privacy policy states that video and audio from medical telehealth visits may be recorded (behavioral health visits are not), and that MDLIVE may convert recordings to text and perform machine learning using AI programs on the data it receives. Use of the telehealth service counts as consent to recording, rather than an explicit opt-in, and stated purposes include 'behavior modification,' 'engagement' and 'efficiency.'
Cigna Spends $8.25 Million on Federal Lobbying in 2024 Amid PBM Reform Push
Cigna disclosed $8.25 million in federal lobbying expenses for 2024, plus more than $3.8 million on state lobbying by consultants, as Congress weighed PBM reform. The company's lobbying report says it advocates for policies that let health plans and PBMs keep offering their products.
Cigna Sells Medicare Business to HCSC for $3.7 Billion
Cigna agreed to sell its Medicare Advantage, Medicare Supplement, Part D, and CareAllies businesses to Health Care Service Corporation for approximately $3.7 billion. The company held only 2% national Medicare market share and margins had fallen below its 4-5% target. Proceeds were directed primarily toward share repurchases, further prioritizing shareholder returns.
Cigna Announces $3.2 Billion Accelerated Share Repurchase
Cigna announced a $3.2 billion accelerated share repurchase and said it was on track to buy back $5 billion of stock in the first half of 2024. CEO David Cordani said the company continued to expect the majority of discretionary cash flow to be used for share repurchase that year.
Evernorth Care Group Lays Off 261 Workers in Arizona
Evernorth Care Group, Cigna's Arizona care delivery group, laid off 261 employees and announced it would close its ambulatory surgery center, audiology, general surgery and urgent care services, with two locations closing. The cuts were disclosed in an Arizona WARN notice at the end of May 2024.
FTC Releases Interim Report Slamming PBM Industry Practices
The FTC released its interim report from the PBM investigation, accusing major PBMs including Express Scripts of anticompetitive conduct, vertically integrating to increase profits, and discouraging competition. The report detailed how PBMs leveraged their market dominance to steer patients toward affiliated pharmacies and inflate drug costs through rebate structures.
Cigna Launches MDLIVE E-Treatment Asynchronous Urgent Care
Cigna Healthcare launched E-Treatment through MDLIVE for employer and individual-market customers: patients complete an 8-10 minute virtual clinical interview and typically receive a diagnosis and treatment plan within an hour without speaking to a clinician. Prescriptions are sent to the customer's preferred pharmacy, and cases can be escalated to a video visit or in-person care. The option grew out of Evernorth's 2023 Bright.md purchase.
Express Scripts Sues FTC Over PBM Report
Express Scripts sued the FTC in federal court in Missouri, calling the agency's July 2024 report on PBMs defamatory and demanding it be retracted. The lawsuit asked a judge to order the report taken down and to recuse Chair Lina Khan from matters involving the company, marking an aggressive posture of suing the regulator investigating it.
FTC Sues Express Scripts and Two Other PBMs Over Insulin Pricing
The FTC filed an administrative complaint against Express Scripts, CVS Caremark, and OptumRx and their affiliated group purchasing organizations, alleging the three largest PBMs engaged in anticompetitive and unfair rebating practices that artificially inflated insulin list prices. Together the three PBMs administer about 80% of all U.S. prescriptions. The FTC alleged PBMs favored high-list-price, highly rebated insulins and shifted costs to patients.
Evernorth Opens Hyderabad Global Capability Centre
Evernorth inaugurated its first global capability centre outside the U.S. in Hyderabad, India. The centre grew from eight employees in April 2024 to about 700 staff and was on track to pass 1,000 employees by early 2025, drawing on local tech, analytics and engineering talent.
Cigna Reports 34% Income Drop Despite Revenue Growth, Raises Dividend 8%
The Cigna Group reported full year 2024 results showing net income fell 34% year-over-year to $3.4 billion despite $247.1 billion in revenue (up 27%). The board increased the quarterly dividend 8% to $1.51 per share. CEO David Cordani received $23.3 million in total compensation, a 279:1 CEO-to-employee pay ratio, while layoffs and service cuts continued across the organization.
Cigna Reshuffles C-Suite, Evernorth CEO Eric Palmer Departs
Cigna consolidated oversight of both Cigna Healthcare and Evernorth under CFO Brian Evanko, who became COO. Evernorth CEO Eric Palmer departed after 25 years with the company, having been paid $8.9 million in 2023. The restructuring signaled Cigna's prioritization of financial optimization over operational independence of its health services divisions.
Michigan AG Files Antitrust Lawsuit Against Express Scripts
Michigan Attorney General Dana Nessel filed an antitrust lawsuit in federal court against Express Scripts and Prime Therapeutics, alleging that since a December 2019 agreement the two conspired to suppress pharmacy reimbursement rates. The complaint alleges Express Scripts controls 89% of Michigan's PBM services market, exceeding 94% in regions like Jackson and Muskegon, and that the arrangement helped create pharmacy deserts in half of Detroit's neighborhoods and drove independent pharmacies out of business.
MDLIVE Users Report Persistent Billing Errors and Service Degradation
Accumulated reviews document service and billing problems. A June 2025 Trustpilot review from a five-year Cigna MDLIVE user reported lab orders stuck in a 'national outage' for about three years, referrals that did not work, and heavy pushing of Express Scripts pharmacy delivery. BBB complaints describe 45-day refund reviews and representatives unable to fix acknowledged billing errors; reviewers on SmartCustomer (formerly Sitejabber) report providers hanging up mid-consultation. MDLIVE holds an F rating from the BBB and a 1.4 Trustpilot TrustScore.
Evernorth Says MD Live Serves 62 Million Members
Announcing MD Live's inclusion on TIME's list of top health tech companies, Evernorth said the service reaches 62 million people through health plans and employers, with about 2,400 board-certified providers, 93% client retention and a self-reported member Net Promoter Score of 74. It said E-Treatment was now available around the clock where state law allows.
FTC Secures Landmark Settlement with Express Scripts on Insulin Pricing
The FTC announced a landmark settlement with Express Scripts requiring fundamental changes to PBM business practices. Express Scripts must stop preferring high-list-price drugs on standard formularies, delink manufacturer compensation from list prices, increase transparency on drug spending, disclose broker payments, and reshore its Ascent Health GPO from Switzerland to the U.S. The FTC said the changes are expected to cut patients' out-of-pocket costs for drugs like insulin by up to $7 billion over 10 years.
Cigna Reports $3.6 Billion in 2025 Buybacks, Raises Dividend
Cigna reported 2025 revenue of $274.9 billion, said it repurchased 11.9 million shares for about $3.6 billion during the year, and raised its quarterly dividend from $1.51 to $1.56 a share.
Cigna to Lay Off About 2,000 Workers Worldwide
Cigna said it would lay off roughly 2,000 employees, just under 3% of its workforce, by the end of February 2026 to cut costs, five days after reporting 2025 results and raising its dividend. The company did not say which roles or units would be affected.
Cigna Names Brian Evanko CEO, Succeeding Cordani
Cigna announced that president and COO Brian Evanko would become CEO on July 1, 2026, with David Cordani becoming executive chair of the board, an insider succession that leaves Evernorth and MDLIVE under the same leadership team.
MD Live First to Earn NCQA Virtual Care Accreditation in All 50 States
MD Live became the first virtual care organization to earn NCQA Virtual Care Accreditation for both primary and urgent care in all 50 states. The standards cover patient safety, care coordination, triage, clinical protocols, follow-up, record keeping, referrals and data exchange.
Express Scripts Sues to Block Tennessee Law Separating PBMs and Pharmacies
Express Scripts sued in federal court to block Tennessee's FAIR Rx Act, which from 2028 bars pharmacies affiliated with PBMs and insurers from operating in the state, arguing it is unconstitutional and preempted by ERISA and TRICARE. The National Community Pharmacists Association said the PBM industry and its allies spent more than $7 million and hired more than 60 lobbyists trying to kill the bill.
Court Dismisses PBMs' Countersuit Against FTC After Insulin Settlements
The 8th Circuit dismissed the countersuit Express Scripts, Caremark and Optum Rx brought against the FTC over its insulin pricing case, after the parties jointly asked to end it. Express Scripts had settled with the FTC in February 2026; Healthcare Dive noted the deal was largely seen as positive for the PBM, which was already pursuing many of the required reforms.
Cigna Slows Buybacks to About $250 Million in 2026
Cigna reported second-quarter 2026 revenue up 7% to $71.7 billion and said that year to date through July 29, 2026 it had repurchased 0.9 million shares for about $250 million, far below the $3.6 billion it bought back in 2025.
MDLIVE and Evernorth Settle Patient Portal Tracking Claims for $3.5 Million
In Kingsbury v. Evernorth Health (Hillsborough County, Florida, Case No. 26-CA-006880), MDLIVE and Evernorth agreed to pay up to $3.5 million to settle claims that sensitive information and private communications on MDLIVE's patient portal were disclosed to Google and Meta without consent, in violation of Florida and federal wiretap law. The class covers portal users from May 30, 2023 to August 11, 2025; members may receive up to $15. The defendants deny wrongdoing, and final approval is set for January 2027.
Evidence (45 citations)
D1: User Value Erosion
D2: Business Customer Exploitation
D3: Shareholder Extraction
D4: Lock-in & Switching Costs
D5: Twiddling & Algorithmic Opacity
D6: Dark Patterns
D7: Advertising & Monetization Pressure
D8: Competitive Conduct
D9: Labor & Governance
D10: Regulatory & Legal Posture
Scoring Log (7 entries)
Checked 81 items (40 timeline, 34 evidence, 5 milestones, 2 alternatives) + prose. 26 verified, 35 corrected (9 date-only), 16 re-sourced, 4 removed. Invented: ~$1B MDLIVE price (10-K: $2.0B); 'up to 10,000' 2024 layoffs (junk-only, cannybusiness.com); 'Chairman Barry Diller's Evernorth' (Cordani is Cigna chairman/CEO); Bright.md 'AI-mediated triage' (TechTarget: not AI/ML); $6.8M 2024 lobbying (Cigna report: $8.25M federal); Breakthrough in '12 states' (release: ten). Removed: unsourced 2017 Ohio auditor item, TRICARE article cited as MDLIVE Rx routing, unsupported 2022 BBB surge, dead junk layoff source.
52->41. Parent (Cigna/Evernorth/Express Scripts) conduct weighted only as context where it touches MDLIVE. D1 6->4 (recalibration: App Store 4.7/94K and 2026 NCQA accreditation offset complaint-site ratings; provider-choice claim weakened by fact audit), D2 5->3 (correction: no evidence of client/clinician fee extraction; Express Scripts routing rests on one review, E-Treatment sends Rx to preferred pharmacy), D3 6->4 (recalibration: parent buybacks weighted as context; also junk 10,000-layoff claim removed and 2026 buybacks cut to ~$250M), D4 5->3 (recalibration: no network effects, many competitors, records access), D7 5->4 (recalibration: no in-product ads; Rx routing weakened; CCPA share/sell for ad targeting keeps 4), D8 5->4 (recalibration: crowded telehealth market; parent PBM antitrust weighted as context), D10 6->5 (recalibration: parent weighting, partly offset by event: $3.5M 2026 portal-tracking settlement). D5, D6, D9 unchanged. Eras: 'Evernorth Acquisition' re-dated 2021-05-01->2021-04-19 (deal close); 'Integration Deepens' re-dated 2023-10-01->2023-10-10 (Bright.md) and merged with 'FTC Enforcement Era' (2026-02-20 was an assessment date; no MDLIVE-level inflection since 2023); 2 kept. Trajectory worsening->stable. Since Feb 2026: $3.5M Kingsbury portal-tracking settlement, NCQA accreditation, Cigna 2,000 layoffs, Evanko CEO, Express Scripts Tennessee suit, FTC countersuit dismissed, Cigna buybacks slowed to ~$250M.
Removed typed-in site scores from alternatives text (they go stale on re-score; the page shows live scores). No other changes.
No material changes since 2026-02-20. Checked MDLIVE/Evernorth/Cigna news, leadership, layoffs, pricing, privacy, and regulatory actions: insider CEO succession (Evanko, effective 2026-07-01), ~2,000 Feb 2026 layoffs, Express Scripts' June 2026 Tennessee PBM lawsuit, and the ACA exchange exit are all continuations of trends already priced into D3/D9/D10; no dimension shifts bands.